-
teamstepps.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18
February 1, 2022
Buprenorphine
-
patientregistry.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18
February 1, 2022
Buprenorphine
-
ahrqpubs.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18
February 1, 2022
Buprenorphine
-
healthcare411.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18
February 1, 2022
Buprenorphine
-
cahps.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18
February 1, 2022
Buprenorphine
-
monahrq.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18
February 1, 2022
Buprenorphine
-
talkingquality.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2
April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18
February 1, 2022
Buprenorphine
-
ce.effectivehealthcare.ahrq.gov/news/newsletters/e-newsletter/index.html?order=field_date_created&page=1&sort=asc
January 19, 2022 - 25, 2022
AHRQ Stats: Hospital Admission Emergency Department Visits
February 1, 2022
Buprenorphine
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/drug-use-illicit-primary-care-interventions-for-children-and-adolescents
August 30, 2018 - medically managed withdrawal, or medication-assisted treatment (e.g., methadone maintenance programs, buprenorphine
-
www.ahrq.gov/research/findings/studies/index.html?page=95
January 01, 2024 - Two of these profiles, primarily alcohol and primarily buprenorphine were at increased and accelerated … nonmedical use of opioids but were unique in their respective near daily use of alcohol and nonmedical buprenorphine
-
psnet.ahrq.gov/web-mm/overdose-gabapentin-and-oxycodone-patient-end-stage-renal-disease-case-appropriate
October 31, 2023 - compared with other opioids and may be used with caution and close monitoring in patients with CKD. 12
Buprenorphine … Therefore, buprenorphine and hydromorphone are considered first-line in the management of pain in patients … )
Dialyzable
Recommended
Hydromorphone
1-2 mg oral every 4 h as needed
Yes
Buprenorphine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
November 01, 2020 - (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone
or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or
morphine or oxycodone … months, randomised, placebo-controlled
evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine … Efficacy and tolerability of buccal
buprenorphine in opioid-experienced patients with moderate to severe … Efficacy and tolerability of buccal buprenorphine in opioid-
naive patients with moderate to severe chronic
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/ambulatory/6bb-toolkit-fasttrack.pdf
January 12, 2021 - Medications such as
buprenorphine, naltrexone, and methadone are needed for patients with OUD. … Clinics find that offering buprenorphine treatment on-site allows
them to provide their patients a full … database
• Patient agreements
• Patient education
• Tapering of opioids
• Use of naloxone
• Use of buprenorphine
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/ambulatory/Six-Building-Blocks-Self-Assessment.pdf
December 08, 2021 - • Patient agreements
• Patient education
• Tapering of opioids
• Use of naloxone
• Use of buprenorphine
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/ambulatory/6bb-self-assessment-tool.pdf
December 08, 2021 - • Patient agreements
• Patient education
• Tapering of opioids
• Use of naloxone
• Use of buprenorphine
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/ambulatory/6bb-self-assess-tool.pdf
December 22, 2021 - • Patient agreements
• Patient education
• Tapering of opioids
• Use of naloxone
• Use of buprenorphine
-
www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/886.html
October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine
-
www.cahps.ahrq.gov/news/newsletters/e-newsletter/886.html
October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine
-
www.qualitymeasures.ahrq.gov/news/newsletters/e-newsletter/886.html
October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine
-
healthcare411.ahrq.gov/news/newsletters/e-newsletter/886.html
October 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine